Opening book details…
About this Medicine article
Cyclacel Pharmaceuticals' phase II trial of sapacitabine in elderly AML* patients has been expanded to include patients with MDS** is a Medicine article available to read on EtoBox.
It is typically read by researchers, students, and practitioners in Medicine.
- Publisher
- Adis International Limited (now part of Wolters Kluwer Health); Springer-Verlag; Springer Science and Business Media LLC (ISSN 1173-8324)
- Published
- 2008
- Field
- Medicine (Health Sciences)